Browse by author
Lookup NU author(s): Fiona Fenwick, Professor Margaret Bassendine, Dr Kaushik Agarwal, Professor Debra Bevitt, Dr Wanna Pumeechockchai, Professor Alastair BurtORCiD, Emeritus Professor Geoffrey Toms
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background: Patients with common variable immunodeficiency may exhibit rapidly progressive hepatitis when infected with hepatitis C virus (HCV), leading to cirrhosis and liver failure. Liver transplantation in these patients may result in a cholestatic form of HCV reinfection with exceptionally high virus loads. Aims: To report an immunohistochemical investigation of the pretransplant and post-transplant liver of one such patient. Methods/Results: On immunohistochemical staining of frozen sections with anti-HCV core monoclonal antibody or fluorescein labelled human polyclonal anti-HCV IgG, no HCV antigens were demonstrated in the native cirrhotic liver removed at transplant, despite a viral load of 106.4 genomes/g. The transplanted liver, collected six weeks post-transplant, exhibited cholestatic recurrent hepatitis, had an HCV virus load of 1010 genomes/g of liver, and revealed HCV antigen in the cytoplasm of most hepatocytes, with a pronounced periportal distribution. No virus antigen was demonstrable in other cell types. The core antigen was also detected in paraffin wax embedded, formaldehyde fixed tissue of this liver after high temperature antigen retrieval, but not in the native cirrhotic liver or a selection of HCV positive livers collected pretransplant from immunocompetent patients. Attempts to delineate the distribution of E1, NS3, and NS4 antigens were unsuccessful because monoclonal antibodies to these antigens produced "false positive" staining of foci of hepatocytes in the post-transplant livers of HCV seronegative patients with cholestasis. Conclusion: This case provided an opportunity to study the natural development of HCV during acute infection in the absence of an immune response, and may help to elucidate the pathogenesis of HCV recurrence in liver allografts.
Author(s): Fenwick F, Bassendine MF, Agarwal K, Bevitt D, Pumeechockchai W, Burt AD, Toms GL
Publication type: Article
Publication status: Published
Journal: Journal of Clinical Pathology
Year: 2006
Volume: 59
Issue: 2
Pages: 174-178
ISSN (print): 0021-9746
ISSN (electronic): 1472-4146
Publisher: BMJ Publishing Group
URL: http://dx.doi.org/10.1136/jcp.2005.028126
DOI: 10.1136/jcp.2005.028126
PubMed id: 16443734
Altmetrics provided by Altmetric
